Jonathan Tward

Cancer Physician/Scientist
Leader, Huntsman Cancer Institute Genitourinary Cancers Center
Professor of Radiation Oncology

[Daniel E Spratt @DrSpratticus]

X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere.

The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI @US_FDA and dedicated my career to help men and their families suffering from PCa

@nytimes @WSJ @FoxNews @CNN @NBCNews @Reuters @ASCO @PCFnews @DeptofDefense

[Jonathan Tward @prostatemd]

@snseyedinMD @ASCO Crickets! But fun running into you @asco

[Ryan Hutten, MD @DrHut10]

In our latest publication @prostatemd @sky__john and @BismarckOdeiMD and I demonstrate the prognostic utility of the cell cycle progression score for patients with localized prostate cancer https://t.co/MfhGh5beqC #pcsm @huntsmancancer @JCOPO_ASCO

[Jonathan Tward @prostatemd]

@BioprotectS @huntsmancancer @Huntsman_GU This is a very impressive perirectal spacer. I have done a bunch of cases now. Perfect space every time so far, adaptable, and moveable. Very easy to apply. An outstanding tool in a category with several good options

[Jonathan Tward @prostatemd]

@DrSpratticus @UHhospitals @DanSimonMD Congratulations Dan! Very well earned.

[Daniel E Spratt @DrSpratticus]

Tweetorial
on our recently published paper in @NEJMEvidence on the development and validation of the 1st predictive biomarker to guide ADT use in prostate cancer.

Enjoy!

#PCSM @arteraAI @NRGonc @felixfengmd @DrHowardSandler @EdwardSchaeffer @prostatemd @AarmstrongDuke

[Jonathan Tward @prostatemd]

@neerajaiims @US_FDA @PCFnews @OncoAlert @urotoday @huntsmancancer @montypal @DrChoueiri @PGrivasMDPhD @NeliMUlrich @shilpaonc @AzadOncology @OncBrothers @charlesryanmd @WisdomVania @VivekSubbiah Congratulations to Neeraj and everyone involved with this amazing trial. Amazing accomplishment to bring a new therapy to fight metastatic prostate cancer. @Huntsman_GU @huntsmancancer

[Jonathan Tward @prostatemd]

@DrSpratticus @ASCO @ASTRO_org @HimanshuNagarMD @DrRanaMcKay @AlbertoBossial @Prof_Nick_James @PCaParker Beautifully summarized overview of how RT adds value for patients with low volume mCRPC

[Jonathan Tward @prostatemd]

@neerajaiims @PGrivasMDPhD @ASCO @OncoAlert @urotoday @PCFnews @TiansterZhang @PBarataMD @umangtalking @montypal @DrChoueiri @NazliDizman @FabioSchutz78 @DrYukselUrun @nsayeghmd @AzadOncology Really cool to see that RT not only had oncologic benefit, but preserved and improved GU quality of life over omitting it.

[Neeraj Agarwal, MD, FASCO @neerajaiims]

#ASCO23 @asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert @urotoday @PCFnews

[GU Cancer Research Program @HuntsmanCancer @Huntsman_GU]

Join us for the #HuntsmanSportsFest to help raise money for #prostatecancer research at HCI #ReasonToHope We can end cancer — together. Will you make a donation to help support our fundraising goal today? Weblink👉 https://t.co/p7KG60Un9b @huntsmancancer @BogdanaSchmidt @ASanchez_UroOnc @prostatemd @sky__john @NeliMUlrich @helops79 @neerajaiims @nsayeghmd @umangtalking @maughanonc @vinay_onc

[Jonathan Tward @prostatemd]

Alas! My medical scribes always get into medical school and leave me 😉. If you know a smart college grad who would like to work as my scribe/research assistant for at least 1 year @huntsmancancer . Please encourage them to apply: https://t.co/nRq4E6VAV7

[Jonathan Tward @prostatemd]

Have a blast, and support men with prostate cancer! @Huntsman_GU @huntsmancancer

[UroToday.com @urotoday]

Ability of STAR-CAP staging system to prognosticate risk of subsequent therapies after initial treatment of M0 #ProstateCancer. Presented by @prostatemd @huntsmancancer. @ASCO #GU23 written coverage by @tchandra_uromd @JEFFUrology > https://t.co/tRCVu3vwvo

[Jonathan Tward @prostatemd]

@dr_coops @DrSpratticus @soares_uro @PCFnews @urotoday @UCSFUrology 90% pad wearing seems high

[UroToday.com @urotoday]

Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic #ProstateCancer to bone. Presentation by @prostatemd @huntsmancancer. @ASCO #GU23 coverage by @WallisCJD > https://t.co/ZEwUluQFIX

[Jonathan Tward @prostatemd]

@neerajaiims @Huntsman_GU @huntsmancancer leads off the #GU23 meeting with results from TALAPRO-2 . Go Utes @UofUHealth

[Sean Collins Prostate SBRT @ USF Health @SbrtSean]

Genomic classifiers in personalized prostate cancer radiotherapy approaches - a systematic review and future perspe… https://t.co/rMNCnaPLtW

[Daniel E Spratt @DrSpratticus]

Twitterverse Poll:

The ongoing healthcare financial crisis and workforce challenges will lead over 5 yrs…:

Comment other ideas!

I would appreciate if you reply and retweet to get a broad perspective.

@seanmmcbride @subatomicdoc @VPrasadMDMPH @EricTopol @ASCO @ASTRO_org

[Samuel Marcrom @SamuelMarcromMD]

Have you listened to the latest @QuadShotNews podcast yet?

Jonathan Tward describes where we are and where we are going in prostate cancer.

Check it out here: https://t.co/tIzxmQqCHo

@ASTRO_org @LauraDoverMD @prostatemd @huntsmancancer @ACRORadOnc #radonc